+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Diagnostic Enzyme Global Market Report 2024 - Product Thumbnail Image

Diagnostic Enzyme Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Oligonucleotide Therapy Global Market Report 2024 - Product Thumbnail Image

Oligonucleotide Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Oncolytic Virus Therapy Global Market Report 2024 - Product Thumbnail Image

Oncolytic Virus Therapy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Systemic Sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
From
From
Diabetic Macular Edema Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Diabetic Macular Edema Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • March 2020
  • 421 Pages
  • Global
From
From
From
Loading Indicator